The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-hydroxy-5-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]benzoic acid ID: ALA4538480
PubChem CID: 6483726
Max Phase: Preclinical
Molecular Formula: C18H12N2O6S
Molecular Weight: 384.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(NS(=O)(=O)c2ccc3c4c(cccc24)C(=O)N3)ccc1O
Standard InChI: InChI=1S/C18H12N2O6S/c21-14-6-4-9(8-12(14)18(23)24)20-27(25,26)15-7-5-13-16-10(15)2-1-3-11(16)17(22)19-13/h1-8,20-21H,(H,19,22)(H,23,24)
Standard InChI Key: ALNRIGYRTBFZIT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
5.2952 -14.5278 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7080 -13.8221 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.8904 -13.8175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5851 -11.7832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5840 -12.6027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2920 -13.0117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9996 -12.5986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7082 -13.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4164 -12.5949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4117 -11.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9989 -11.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7005 -11.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4720 -10.5789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5781 -10.5745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2914 -11.3744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1093 -9.9051 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4184 -14.2300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1251 -13.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8311 -14.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5374 -13.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5358 -13.0023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8222 -12.5956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1188 -13.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2420 -12.5911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2458 -14.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2474 -15.0448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9528 -13.8176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
15 4 2 0
11 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 12 2 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
14 16 2 0
8 2 1 0
2 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
20 25 1 0
25 26 2 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.37Molecular Weight (Monoisotopic): 384.0416AlogP: 2.61#Rotatable Bonds: 4Polar Surface Area: 132.80Molecular Species: ACIDHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.66CX Basic pKa: ┄CX LogP: 2.57CX LogD: -1.05Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -0.99
References 1. Wang Y, Dou X, Jiang L, Jin H, Zhang L, Zhang L, Liu Z.. (2019) Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia., 171 [PMID:30925338 ] [10.1016/j.ejmech.2019.03.039 ]